Liver senolytics, muscle lipids and AMPK
A phase-2 MASH fibrosis signal, a cardiolipin recovery path, and direct AMPK lifespan gains.
重要的健康與長壽新聞,經過證據核查,並以不誇張的方式解釋。沒有每日噪音,也沒有奇蹟承諾。
封存
每一期已發布的內容都會保留在這裡,可免費開啟並輕鬆分享。請從下方最新的一期開始。
A phase-2 MASH fibrosis signal, a cardiolipin recovery path, and direct AMPK lifespan gains.
A blood proxy for senescence burden, an oral bacterium linked to slower aging, and a shared sleep path.
A middle-age trial, a faster path to test longevity drugs, and many healthy eating patterns.
Three September papers on ageing blood markers, organ clocks, and sleep-wave integrity.
Plus a frailty trial, Bhutan's rabies milestone and an Lp(a) outcome miss.
Plus why a refill is not adherence, and what a retraction changes.
Why responsive ageing clocks are signals rather than health verdicts, plus an Alzheimer blood panel and a null stroke-care trial.
52 週結果為經同儕審查的口服 GLP-1 研究增添了什麼,以及組織老化、可長期保存的血漿和「結果階梯」。
我們的篩選器
依據證據解釋重要的健康與長壽資訊。
依據證據解釋重要的健康與長壽資訊。
我們每週二聚焦於最值得關注的證據,整理成清晰、五分鐘即可讀完的內容。
不誇大的訊號
免費,每週二發送。確認一次即可加入。